Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Mar, 22 2025
Jul, 10 2025
Nov, 1 2025
Apr, 26 2025
Aug, 14 2025